Crescent Grove Advisors, LLC Biovie Inc. Transaction History
Crescent Grove Advisors, LLC
- $931 Million
- Q1 2024
A detailed history of Crescent Grove Advisors, LLC transactions in Biovie Inc. stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 27,500 shares of BIVI stock, worth $11,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,500
Previous 19,500
41.03%
Holding current value
$11,000
Previous $24,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BIVI
# of Institutions
57Shares Held
7MCall Options Held
51.7KPut Options Held
353K-
Altium Capital Management LP New York, NY3.01MShares$1.21 Million0.9% of portfolio
-
Sabby Management, LLC Upper Saddle River, NJ689KShares$275,65412.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA645KShares$257,8300.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE600KShares$239,9582.37% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny347KShares$138,9600.0% of portfolio
About BIOVIE INC.
- Ticker BIVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,165,300
- Market Cap $12.1M
- Description
- BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...